Clinical Trial Update: Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TAK-438 (vonoprazan) for preventing recurrent gastric or duodenal ulcers during low-dose aspirin therapy; the study has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Drugs mentioned

• TAK-438 (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastric Ulcers, Duodenal Ulcers | Phase 3 | Status: COMPLETED